They feature short videos or before/after montages showing people losing weight in just one week. The captions often mention GLP-1 a trending keyword because of the popularity of real weight loss medications
Amycretin (Novo Nordisk): The Dual Approach Novo Nordisk, the maker of Ozempic and Wegovy, is developing amycretin, a dual GLP-1 and amylin agonist
In addition to treating obesity and Type 2 diabetes, GLP-1s have also shown promise with substance use disorders (SUD)
Most researchers report that shedding peaks around months 3-6 of treatment and resolves by months 9-12
It is the role that we play as an advocate to those that entrust us with their care
In a recent tirzepatide (Zepbound) study, a weight loss plateau was defined as "a period when body weight remains relatively stabledefined as less than a 5% change over a 3-month periodafter an initial phase of weight loss." What that means isyou can do everything right and you'll still hit a GLP-1 weight loss plateau